Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广

网站主页 >> 化工产品目录 >> Macimorelin>> 市场分析报告
 

Macimorelin市场分析报告

MACIMORELIN - Emerging Insight and Market Forecast - 2030
This report can be delivered to the clients within 48 Hours “ANAMORELIN HCL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cancer Cachexia in 7 Major Markets. A detailed ...

Aeterna Zentaris Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
... Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company ...

Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H2 2020
Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H2 2020'; Growth Hormone Secretagogue Receptor Type 1 (GH Releasing ...

Cancer Cachexia - Pipeline Insight, 2021
... Cancer Cachexia Emerging Drugs Macimorelin: AEterna Zentaris Macimorelin (AEZS 130) is an orally ... , such as AIDS and cancer. Macimorelin was approved by the FDA in ... name Macrilen for oral solution. Macimorelin stimulates GH release by activating growth ...

Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H1 2020
Growth Hormone Secretagogue Receptor Type 1 - Pipeline Review, H1 2020 SUMMARY Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Growth hormone secretagogue receptor (GHSR) also known as ghrelin ...

Growth Hormone Secretagogue Receptor Type 1 - Drugs In Development, 2021
Growth Hormone Secretagogue Receptor Type 1 - Drugs In Development, 2021 SUMMARY Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) pipeline Target constitutes close to 15 molecules. Out of which ...

Global Growth Hormone (GH) Testing for Traumatic Brain Injury (TBI) Market Growth (Status and Outlook) 2025-2031
... Tolerance Test Glucagon Stimulation Test Macimorelin Stimulation Test Arginine Stimulation Test ...

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2018
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2018 SUMMARY Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) pipeline ...

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) – Pipeline Review, H1 2018
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) – Pipeline Review, H1 2018 SUMMARY According to the recently published report 'Growth Hormone Secretagogue Receptor Type 1 – Pipeline Review, H1 2018'; ...

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY According to the recently ...

Ghrelin receptor agonists - Pipeline Insight, 2022
... Zentaris Key Products Anamorelin HCl Macimorelin

Cachexia - Pipeline Insight, 2021
... Key Products Ruxolitinib GCWB 204 Macimorelin AV 380 ART 2713 TCMCB-07 ACM ...

Cachexia - Pipeline Review - 2019
... HCl Kanglaite MT-102 Cryptic-Fc Apd209 Macimorelin Ruxolitinib Phosphate Av-380 Ip1510 Rq-00433412 ...

Growth Hormone Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major growth hormone deficiency markets reached a value of US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.61% during 2024-2034. The growth hormone ...

Somatotropin Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major somatotropin deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The somatotropin deficiency market has been comprehensively analyzed in IMARC's new report titled "Somatotropin Deficiency Market: Epidemiology, Industry ...

Cancer Cachexia: Drug Development Pipeline Study, H1 2018
Cancer Cachexia pipeline comprises of 17 drugs under development as of March 2018. Of these, 1 drug is in Phase 1 and 4 drugs in phase 2 with 1 drug in Phase 3. Further, 10 drugs are in Pre-clinical stage and 1 drug is in research phase. 26 companies are ...

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review
... . The company’s lead product, Macrilen (macimorelin), a ghrelin receptor agonist and orally ...




Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系